NasdaqCM - Delayed Quote • USD
Jasper Therapeutics, Inc. (JSPR)
At close: April 25 at 4:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 590,900 | 6 |
| Sales | 8,865 | 2 |
| Net Shares Purchased (Sold) | 582,035 | 8 |
| Total Insider Shares Held | 755k | -- |
| % Net Shares Purchased (Sold) | 336.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MAHAL JEETINDER SINGH Chief Operating Officer | Sale at price 26.44 per share. | Direct | 23,792 | Mar 12, 2024 |
| MAHAL JEETINDER SINGH Chief Operating Officer | Conversion of Exercise of derivative security at price 7.10 per share. | Direct | 6,390 | Mar 12, 2024 |
| CARLYLE GROUP, INC. Unknown | Purchase at price 17.36 per share. | Indirect | 3,298,400 | Feb 8, 2024 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP Beneficial Owner of more than 10% of a Class of Security | Purchase at price 17.36 per share. | Indirect | 6,076,000 | Feb 8, 2024 |
| WIGGANS THOMAS G Director | Purchase at price 0.65 per share. | Direct | 6,486 | Nov 28, 2023 |
| WIGGANS THOMAS G Director | Purchase at price 0.64 per share. | Direct | 6,383 | Nov 21, 2023 |
| WIGGANS THOMAS G Director | Purchase at price 0.60 - 0.63 per share. | Direct | 18,240 | Nov 20, 2023 |
| LIS WILLIAM Director | Sale at price 0.85 per share. | Direct | 6,777 | Oct 13, 2023 |
| MAHAL JEETINDER SINGH Chief Operating Officer | Sale at price 1.66 per share. | Direct | 14,915 | Jun 13, 2023 |
| MAHAL JEETINDER SINGH Chief Operating Officer | Conversion of Exercise of derivative security at price 0.71 per share. | Direct | 6,390 | Jun 13, 2023 |
| FRENCH ANNA LOUISE Director | Sale at price 1.48 per share. | Direct | 10,360 | Apr 14, 2023 |
| EMSTER KURT VON Director | Sale at price 1.49 per share. | Direct | 13,524 | Apr 13, 2023 |
| LIS WILLIAM Director | Sale at price 1.44 per share. | Direct | 12,240 | Apr 13, 2023 |
| CARLYLE GROUP, INC. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.50 per share. | Indirect | 4,700,000 | Jan 27, 2023 |
| QIMING U.S. HEALTHCARE FUND II, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.50 per share. | Indirect | 3,999,999 | Jan 27, 2023 |
| ROCHE HOLDING, LTD., Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.89 per share. | Indirect | 141,750 | Jan 25, 2023 |
| MARTELL RONALD A Chief Executive Officer | -- | Direct | -- | Oct 12, 2022 |
| EMSTER KURT VON Director | -- | Direct | -- | Oct 12, 2022 |
| LIS WILLIAM Director | -- | Direct | -- | Oct 12, 2022 |
| KLEIN LAWRENCE OTTO Director | -- | Direct | -- | Oct 12, 2022 |
| NOLET CHRIS Director | -- | Direct | -- | Oct 12, 2022 |
| MAHAL JEETINDER SINGH Chief Operating Officer | -- | Direct | -- | Oct 12, 2022 |
| SHIZURU JUDITH ANNE M.D., PH.D. Director | -- | Direct | -- | Oct 12, 2022 |
| FRENCH ANNA LOUISE Director | -- | Direct | -- | Oct 12, 2022 |
| LIS WILLIAM Director | Sale at price 2.02 - 2.08 per share. | Direct | 101,434 | Jun 27, 2022 |
| LIS WILLIAM Officer and Director | -- | Direct | -- | Mar 21, 2022 |
| HOFFEN HOWARD I Former | -- | Indirect | -- | Sep 24, 2021 |
| CLIFFORD KENNETH F Former | -- | Indirect | -- | Sep 24, 2021 |
| VENKATARAMAN BALAJI Former | -- | Indirect | -- | Sep 24, 2021 |
| AMPLITUDE HEALTHCARE HOLDINGS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Sep 24, 2021 |
| AGRAWAL NEERAJ Director and Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Sep 21, 2021 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 9.92 per share. | Indirect | 1,516,599 | Apr 23, 2021 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 9.97 per share. | Indirect | 20,538 | Apr 19, 2021 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.45 - 10.50 per share. | Indirect | 134,005 | Feb 22, 2021 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.40 per share. | Indirect | 2,205 | Feb 5, 2021 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.40 per share. | Indirect | 1,050 | Jan 14, 2021 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.25 per share. | Indirect | 102,500 | Jan 8, 2021 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.25 per share. | Indirect | 953 | Dec 30, 2020 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.15 - 10.20 per share. | Indirect | 203,500 | Dec 28, 2020 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.05 - 13.65 per share. | Indirect | 220,000 | Dec 15, 2020 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.05 - 10.73 per share. | Indirect | 128 | Dec 7, 2020 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.00 per share. | Indirect | 10,000 | Sep 21, 2020 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 9.99 - 10.00 per share. | Indirect | 10,200 | Sep 18, 2020 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 9.99 per share. | Indirect | 14,805 | Sep 15, 2020 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 9.99 per share. | Indirect | 10 | Sep 8, 2020 |
| GLAZER CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 9.99 per share. | Indirect | 33,946 | Aug 17, 2020 |
Related Tickers
CGEM Cullinan Therapeutics, Inc.
19.25
+1.91%
IGMS IGM Biosciences, Inc.
7.65
-3.89%
OLMA Olema Pharmaceuticals, Inc.
9.83
-3.15%
CLDX Celldex Therapeutics, Inc.
36.26
-2.05%
MRUS Merus N.V.
44.93
+7.05%
ZURA Zura Bio Limited
3.6200
+9.37%
PCVX Vaxcyte, Inc.
60.06
-0.40%
DNTH Dianthus Therapeutics, Inc.
20.99
-1.55%
TRML Tourmaline Bio, Inc.
16.00
+3.83%
SPRO Spero Therapeutics, Inc.
1.4300
+0.70%